A single dose of Johnson & Johnson’s experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid-stage clinical trial, according to interim results published on…

Read more »

The post Johnson & Johnson COVID-19 Vaccine Produces Strong Immune Response in Early Trial appeared first on Hamodia.

In related news:

  1. Defense Ministry to Use Computer Analysis to Find Coronavirus Carriers
  2. Message From Rabbi Dr. Aaron Glatt Regarding Coronavirus Antibodies Testing
  3. FOCUS: Are Asymptomatic COVID-19 Patients Safe or Silent Carriers?
  4. WHO: Vaccine Against COVID-19 Not Certain, Maybe in a Year
  5. Doctors Try Pressurized Oxygen Chambers in COVID Fight